BRPI0512522A - processo para a preparação de sal de sódio de esomeprazol, composto, formulação farmacêutica, e, método de tratamento - Google Patents
processo para a preparação de sal de sódio de esomeprazol, composto, formulação farmacêutica, e, método de tratamentoInfo
- Publication number
- BRPI0512522A BRPI0512522A BRPI0512522-7A BRPI0512522A BRPI0512522A BR PI0512522 A BRPI0512522 A BR PI0512522A BR PI0512522 A BRPI0512522 A BR PI0512522A BR PI0512522 A BRPI0512522 A BR PI0512522A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- sodium salt
- compound
- esomeprazole sodium
- treatment method
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000013078 crystal Substances 0.000 abstract 3
- 238000012986 modification Methods 0.000 abstract 3
- 230000004048 modification Effects 0.000 abstract 3
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58261704P | 2004-06-24 | 2004-06-24 | |
| PCT/SE2005/000954 WO2006001753A1 (en) | 2004-06-24 | 2005-06-20 | New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0512522A true BRPI0512522A (pt) | 2008-03-11 |
Family
ID=35782078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0512522-7A BRPI0512522A (pt) | 2004-06-24 | 2005-06-20 | processo para a preparação de sal de sódio de esomeprazol, composto, formulação farmacêutica, e, método de tratamento |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8658799B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1765806A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5457632B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20130140918A (cg-RX-API-DMAC7.html) |
| CN (3) | CN103772360A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005257709C1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0512522A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2570795C (cg-RX-API-DMAC7.html) |
| HK (1) | HK1197065A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06015031A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ551970A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006001753A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8247566B2 (en) * | 2005-06-08 | 2012-08-21 | Lek Pharmaceuticals D.D. | Crystalline solvate of omeprazole sodium |
| JPWO2007055178A1 (ja) * | 2005-11-08 | 2009-04-30 | 財団法人ヒューマンサイエンス振興財団 | 細胞の分取方法、及び当該方法に用いる基材 |
| US8063074B2 (en) | 2006-05-04 | 2011-11-22 | Dr. Reddy's Laboratories Limited | Polymorphic forms of esomeprazole sodium |
| EP2143722A1 (en) * | 2008-07-09 | 2010-01-13 | Lek Pharmaceuticals D.D. | Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| MX2012009220A (es) | 2010-02-12 | 2012-09-07 | Esteve Quimica Sa | Procedimiento de preparacion de la sal sodica de esomeprazol. |
| CN102746272B (zh) * | 2012-04-11 | 2014-06-25 | 江苏奥赛康药业股份有限公司 | 一种埃索美拉唑钠多晶型物及其制备方法和应用 |
| CN102746273A (zh) * | 2012-05-29 | 2012-10-24 | 江苏奥赛康药业股份有限公司 | 一种埃索美拉唑钠多晶型物及其在注射用药物中的应用 |
| CN104031032B (zh) * | 2014-07-04 | 2016-04-27 | 江苏奥赛康药业股份有限公司 | 一种埃索美拉唑钠化合物及其药物组合物 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4378974A (en) | 1982-06-09 | 1983-04-05 | Allis-Chalmers Corporation | Start-up method for coal gasification plant |
| SE8301182D0 (sv) | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
| WO1993006097A1 (en) | 1991-09-20 | 1993-04-01 | Merck & Co., Inc. | Novel process for the preparation of anti-ulcer agents |
| US6875872B1 (en) | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
| SE9301830D0 (sv) | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| WO1995032957A1 (en) * | 1994-05-27 | 1995-12-07 | Astra Aktiebolag | Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles |
| SE504459C2 (sv) * | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
| SE510666C2 (sv) * | 1996-12-20 | 1999-06-14 | Astra Ab | Nya Kristallmodifikationer |
| SE510650C2 (sv) | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
| SE510643C2 (sv) | 1997-06-27 | 1999-06-14 | Astra Ab | Termodynamiskt stabil omeprazol natrium form B |
| NL1007699C2 (nl) | 1997-12-04 | 1999-06-09 | Medisize Bv | Beademingssysteem. |
| SE9900274D0 (sv) * | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
| DE60023154T2 (de) * | 1999-08-26 | 2006-06-22 | Aaipharma Inc. | Alkoxy-substituierte benzimidazolverbindungen , diese enthaltende arzneimittel und ihre verwendung |
| AU2001276721A1 (en) * | 2000-08-04 | 2002-02-18 | Takeda Chemical Industries Ltd. | Salts of benzimidazole compound and use thereof |
| WO2003089408A2 (en) | 2002-04-22 | 2003-10-30 | Sun Pharmaceutical Industries Limited | Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts |
| WO2004002982A2 (en) | 2002-06-27 | 2004-01-08 | Dr. Reddy's Laboratories Limited | A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
| EA200500673A1 (ru) | 2002-10-22 | 2005-12-29 | Рэнбакси Лабораториз Лимитед | Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе |
| EA011771B1 (ru) * | 2002-12-06 | 2009-06-30 | Никомед Гмбх | Способ получения оптически чистых ингибиторов протонного насоса |
| WO2004089935A1 (en) | 2003-04-10 | 2004-10-21 | Hetero Drugs Limitd | Novel crystalline forms of s-omeprazole magnesium |
| CA2528993A1 (en) * | 2003-06-10 | 2004-12-23 | Teva Pharmaceutical Industries Ltd. | Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
-
2005
- 2005-06-20 CN CN201410063477.4A patent/CN103772360A/zh active Pending
- 2005-06-20 CN CN2013100244957A patent/CN103121992A/zh active Pending
- 2005-06-20 CN CNA2005800208742A patent/CN1972928A/zh active Pending
- 2005-06-20 JP JP2007518003A patent/JP5457632B2/ja not_active Expired - Fee Related
- 2005-06-20 US US11/570,717 patent/US8658799B2/en not_active Expired - Fee Related
- 2005-06-20 BR BRPI0512522-7A patent/BRPI0512522A/pt not_active IP Right Cessation
- 2005-06-20 CA CA2570795A patent/CA2570795C/en not_active Expired - Fee Related
- 2005-06-20 EP EP05754053A patent/EP1765806A1/en not_active Ceased
- 2005-06-20 WO PCT/SE2005/000954 patent/WO2006001753A1/en not_active Ceased
- 2005-06-20 NZ NZ551970A patent/NZ551970A/en not_active IP Right Cessation
- 2005-06-20 MX MXPA06015031A patent/MXPA06015031A/es active IP Right Grant
- 2005-06-20 AU AU2005257709A patent/AU2005257709C1/en not_active Ceased
- 2005-06-20 KR KR1020137032748A patent/KR20130140918A/ko not_active Ceased
- 2005-06-20 KR KR1020137005546A patent/KR20130038949A/ko not_active Withdrawn
-
2012
- 2012-09-18 JP JP2012203798A patent/JP2012246316A/ja active Pending
-
2014
- 2014-10-23 HK HK14110572.9A patent/HK1197065A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8658799B2 (en) | 2014-02-25 |
| HK1197065A1 (en) | 2015-01-02 |
| JP2012246316A (ja) | 2012-12-13 |
| WO2006001753A1 (en) | 2006-01-05 |
| CN103121992A (zh) | 2013-05-29 |
| JP5457632B2 (ja) | 2014-04-02 |
| JP2008503574A (ja) | 2008-02-07 |
| CN103772360A (zh) | 2014-05-07 |
| MXPA06015031A (es) | 2007-02-08 |
| CA2570795A1 (en) | 2006-01-05 |
| NZ551970A (en) | 2010-01-29 |
| US20080039503A1 (en) | 2008-02-14 |
| AU2005257709B2 (en) | 2008-11-13 |
| KR20130140918A (ko) | 2013-12-24 |
| CN1972928A (zh) | 2007-05-30 |
| KR20130038949A (ko) | 2013-04-18 |
| AU2005257709C1 (en) | 2011-02-24 |
| EP1765806A1 (en) | 2007-03-28 |
| AU2005257709A1 (en) | 2006-01-05 |
| CA2570795C (en) | 2013-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0916735B8 (pt) | compostos moduladores de tgr5, composições farmacêuticas compreendendo os mesmos e seus usos | |
| BRPI0507041A (pt) | composto derivados de sulfonamida para o tratamento de doenças seus usos, processo para a preparação dos compostos e combinação de compostos | |
| NO20082124L (no) | Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom | |
| BRPI0508820B8 (pt) | compostos moduladores de receptor de opióide e composição que os compreende | |
| BRPI0406827A (pt) | Processo para a modificação da formação de cristal de droga | |
| EA200870127A1 (ru) | Полициклические производные аминокислот и способы их применения | |
| EA200901138A1 (ru) | Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение | |
| BR112015019720B8 (pt) | Inibidores de (benzil-ciano-metil)-amidas de ácido 2-azabiciclo[2.2.1]heptano-3-carboxílico substituído da catepsina c e composição farmacêutica | |
| BRPI0513717A (pt) | derivados de piridina | |
| BR122017021516B8 (pt) | processo de preparação de uma estrutura de cristal de solvato de (s)-propileno glicol de fórmula ia | |
| BRPI0609719B8 (pt) | derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2 | |
| BRPI0614168A2 (pt) | Composto ou um sal, hidrato, solvato, isoforma, tautômero, isômero óptico farmaceuticamente aceitável ou uma combinação dos mesmos, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psquiátricos, uso de um composto, e, processo para a preparação de um composto | |
| UA109220C2 (uk) | Похідні (4-фенілімідазол-2-іл)етиламіну як модулятори натрієвих каналів | |
| BR112014005389A8 (pt) | Sal cloridrato de 4- (3-metanossulfonil-fenil) -1- propil-piperidina em uma forma cristalina, composição farmacêutica compreendendo o mesmo e usos do dito sal | |
| BRPI0409109A (pt) | novos compostos | |
| BRPI0907844B8 (pt) | compostos e método para modular um receptor de andrógeno, processos de preparação e composição farmacêutica dos mesmos e seus usos | |
| BR112012014180A2 (pt) | composto, composição farmacêutica, uso da composição farmacêutica, e, método para tratar uma doença ou em distúrbio. | |
| ATE411280T1 (de) | Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege | |
| EA200800514A1 (ru) | Замещённые 7-азаиндазолы, содержащие их композиции, способ получения и применения | |
| BR112012033402A2 (pt) | moduladores de canais de íons conforme os compostos heterocíclicos fundidos | |
| BR112012015714A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença neurodegenerativa, método para reduzir a concentração de p-ser-alfa-sinucleina em tecido cerebral, e, método para o tratamento de um câncer | |
| BR112015022096A8 (pt) | compostos moduladores de canal de sódio, composição que os compreende e uso dos mesmos | |
| MX2009011364A (es) | Nuevos derivados de n-(8-heteroariltetrahidronaftalen-2-il) y n-(5-heteroarilcroman-3-il)carboxamida para el tratamiento del dolor. | |
| BRPI0517263A (pt) | novos derivados de sulfonamida como moduladores do receptor de glicocorticóide para o tratamento de doenças inflamatórias | |
| BR112012003464B8 (pt) | compostos de piranil aril metil benzoquinaozlinona, uso dos mesmos, e, composição farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2311 DE 22-04-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |